Evaluating the impact of blood flow on endometrial cancer outcomes
Official title: The Role of Endometrial Blood Flow in Endometrial Cancer
Run by Far Eastern Memorial Hospital · NCT05034991 · Data updated 2026-11-12
This study is trying to see if measuring blood flow in the uterus before surgery can help doctors understand how well patients with endometrial cancer might do after treatment.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 20 Years and up |
| Sex | Women only |
| Enrollment | 75 (estimated) |
| Sponsor | Far Eastern Memorial Hospital Academic / other |
| Locations | 1 site (Banqiao District, New Taipei) |
| Status | Recruiting |
| Started | January 5, 2021 |
| Main results expected | December 31, 2029 |
| Study ends | December 31, 2029 |
| Registry record updated | March 29, 2023 |
| Trial ID | NCT05034991 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are females over 20 years old who have been diagnosed with endometrial cancer.
✕Probably not a fit
Patients under 20 years old will not benefit from this study as they do not meet the eligibility criteria.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to analyze the role of preoperative endometrial blood flow in patients diagnosed with endometrial cancer. Using sonography, the study will assess endometrial volume, vascularity, and blood flow to determine their correlation with patient outcomes. The findings could provide insights into how blood flow characteristics may influence treatment decisions and prognoses for endometrial cancer patients.
Why it matters
Potential benefit: If successful, this study could lead to improved preoperative assessments and tailored treatment strategies for endometrial cancer patients.
How similar studies have gone: While there may be studies examining blood flow in other cancers, this specific focus on endometrial blood flow in relation to cancer outcomes is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: \- \>20 years old female had Endometrial cancer Exclusion Criteria: \- \<20 years old female
Where it's running
-
Department of Obstetrics and Gynecology, Far-Eastern Memorial Hospital
Banqiao District, New Taipei, Taiwan Recruiting
Study contacts
- Study coordinator: Sheng-Mou Hsiao, MD
- Email: smhsiao2@gmail.com
- Phone: +89667000
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Personalized navigation to support rural and Black women with endometrial cancer
This pilot tests a tailored patient-navigation program to help rural and Black patients with endometrial cancer access care and services.
-
CR-002 study in adults with advanced solid tumors
This trial tests CR-002 as a single therapy to see if it is safe and tolerable in adults with locally advanced or metastatic solid tumors
-
Methylation markers in self-samples to help detect gynecological cancers
This study tests whether self-collected urine and vaginal samples can reveal DNA methylation or other genetic markers that indicate endometrial, ovarian, vulvar, or vaginal cancers in women who are at risk or have postmenopausal bleeding.
-
One-Finger Technique to identify the left upper ureter during para-aortic lymphadenectomy
This study tests a new surgical method to help surgeons find the left upper ureter during open para-aortic lymphadenectomy in women with gynecologic cancers.
-
Liquid biopsy screening for early endometrial cancer in regional China
A non-invasive blood test using cell-free DNA is being tested to see if it can detect early endometrial cancer and tell apart benign from malignant uterine lesions.
-
Radiotherapy for gynecologic cancer with up to 10 metastatic sites
This registry follows adults with gynecologic cancer who have 1 to 10 active metastatic lesions and are treated with radiotherapy as part of routine care to see how such treatments work in real-world settings.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.